Global Ectoparasiticides Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Ectoparasiticides Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
An ectoparasiticide is an antiparasitic drug used in the treatment of ectoparasitic infestations. Commonly used ectoparasites are Baishenning, sulfur, lindane, DDT, benzyl benzoate, ivermectin and clomiphene.
The global Ectoparasiticides market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033.
The United States market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key manufacturers of Ectoparasiticides include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Inc., Sanofi, Virbac and Vetoquinol S.A., etc. In 2022, the global top five players had a share approximately % in sales volume, and in term of revenue of Ectoparasiticides, the top five companies hold a share nearly %.
In terms of production side, this report researches the Ectoparasiticides capacity, production, growth rate, market share by manufacturers, region level and country level, from 2018 to 2023, and forecast to 2033.
In terms of sales (consumption) side, this report focuses on the sales of Ectoparasiticides by region (Countries), company, type and application. from 2018 to 2023 and forecast to 2033.
The global Ectoparasiticides market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Ectoparasiticides market. These figures have been provided in terms of both revenue and volume for the period 2018-2033. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis, Inc.
Sanofi
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals Plc
Advance Properties OOD/Huvepharma
By Type
Permethrin
Sulfur
Lindane
Dicophane
Benzyl Benzoate
Ivermectin
Crotamiton
Others
By Application
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Ectoparasiticides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Ectoparasiticides production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4Detailed analysis of Ectoparasiticides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 9China by company, by type and by application, sales, and revenue for each segment.
Chapter 10APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 11Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ectoparasiticides sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.
The global Ectoparasiticides market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033.
The United States market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Ectoparasiticides is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key manufacturers of Ectoparasiticides include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Inc., Sanofi, Virbac and Vetoquinol S.A., etc. In 2022, the global top five players had a share approximately % in sales volume, and in term of revenue of Ectoparasiticides, the top five companies hold a share nearly %.
In terms of production side, this report researches the Ectoparasiticides capacity, production, growth rate, market share by manufacturers, region level and country level, from 2018 to 2023, and forecast to 2033.
In terms of sales (consumption) side, this report focuses on the sales of Ectoparasiticides by region (Countries), company, type and application. from 2018 to 2023 and forecast to 2033.
The global Ectoparasiticides market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Ectoparasiticides market. These figures have been provided in terms of both revenue and volume for the period 2018-2033. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
By Company
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis, Inc.
Sanofi
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals Plc
Advance Properties OOD/Huvepharma
By Type
Permethrin
Sulfur
Lindane
Dicophane
Benzyl Benzoate
Ivermectin
Crotamiton
Others
By Application
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Ectoparasiticides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Ectoparasiticides production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4Detailed analysis of Ectoparasiticides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 9China by company, by type and by application, sales, and revenue for each segment.
Chapter 10APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 11Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ectoparasiticides sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices